Quarterly ResultApr 16, 2026, 03:46 PM
CBIH Cash Plummets to $90; Current Assets Down 94% in Q3
AI Summary
Cannabis Bioscience International Holdings, Inc. reported its Q3 2026 results, revealing a significant deterioration in its financial position. Cash and cash equivalents plummeted to just $90 as of February 28, 2026, down from $12,952 at the end of the prior fiscal year. Total current assets also saw a drastic reduction, falling by approximately 94% to $1,544. The company also indicated that it has not filed all required reports in the preceding 12 months.
Key Highlights
- Cash and cash equivalents plummeted to $90 from $12,952.
- Total current assets decreased by 94% to $1,544.
- Accounts receivable fell to $1,266 from $6,380.
- Related-party receivables reduced to $0 from $9,155.
- Company has not filed all required reports in the last 12 months.